Summary
- Current Price
- As of today, FULC price is $6.94, down -0.57% on
- Current Price All-Time High
- FULC price is currently -79.03% below its historical high of $33.10 set on
- Market Cap
- FULC current market cap is $458M, up +180.85% over the past 365 days
- PE Ratio
- FULC PE ratio is unknown
- Revenue
- FULC current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- The next earnings release for FULC is on
Profile
| Metric | Value |
|---|---|
| Full Name | Fulcrum Therapeutics, Inc. |
| Ticker | NASDAQ: FULC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | fulcrumtx.com |
| Employees | 45 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $6.94 | |
| Price, 1D Change | -0.57% | |
| $458M | ||
| - | ||
| - | ||
| 1.06 | ||
| $0 | ||
| Revenue, 1Y Change | -100.00% | |
| -$1.18 | ||
| EPS, 1Y Change | -653.28% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.18 | ||
| EPS Estimate | N/A | -$1.30 |
| EPS Est. Change | N/A | -9.98% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $6.94 | |
| Price Target | - | $21.50 |
| Price Tgt. Change | - | +209.80% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.14 | -$0.16 | -8.96% | |
| -$1.17 | -$1.18 | -0.88% | |
| -$1.30 | N/A | -9.98% | |
| -$1.60 | N/A | -35.65% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $80.47M | $80.00M | -0.59% | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $6.94 | |
| $8.78 | ||
| SMA 200 vs Price | +26.52% | |
| $9.27 | ||
| SMA 50 vs Price | +33.55% | |
| 1.06 | ||
| $0.55 | ||
| 33.51 | ||
| 51.01% | ||
| 93.14% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.18 | ||
| -$1.39M | ||
| - | ||
| -$84.77M | ||
| - | ||
| -$74.88M | ||
| - | ||
| -$83.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 27.40 | ||
| 27.40 | ||
| - | ||
| - | ||
| 13.99 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.31 | ||
| -1.34 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $349.00M | ||
| $352.31M | ||
| $366.28M | ||
| $357.48M | ||
| $17.28M | ||
| $13.05M | ||
| $6.44M | ||
| $2.40M | ||
| $1.59M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $74.88M | ||
| $83.38M | ||
| $1.39M | ||
| $0.00 | ||
| $1.39M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$60.07M | ||
| $30.72M | ||
| $168.67M | ||
| $314.00K | ||
| -$60.38M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | ||
| Truist Securities | → | |
| B of A Securities | → | |
| RBC Capital | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | → | |
| Truist Securities | ||
| HC Wainwright & Co. | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with FULC
FAQ
What is the ticker symbol for Fulcrum Therapeutics, Inc.?
The ticker symbol for Fulcrum Therapeutics, Inc. is NASDAQ:FULC
Does Fulcrum Therapeutics, Inc. pay dividends?
No, Fulcrum Therapeutics, Inc. does not pay dividends
What sector is Fulcrum Therapeutics, Inc. in?
Fulcrum Therapeutics, Inc. is in the Healthcare sector
What industry is Fulcrum Therapeutics, Inc. in?
Fulcrum Therapeutics, Inc. is in the Biotechnology industry
What country is Fulcrum Therapeutics, Inc. based in?
Fulcrum Therapeutics, Inc. is headquartered in United States
When did Fulcrum Therapeutics, Inc. go public?
Fulcrum Therapeutics, Inc. initial public offering (IPO) was on July 18, 2019
Is Fulcrum Therapeutics, Inc. in the S&P 500?
No, Fulcrum Therapeutics, Inc. is not included in the S&P 500 index
Is Fulcrum Therapeutics, Inc. in the NASDAQ 100?
No, Fulcrum Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Fulcrum Therapeutics, Inc. in the Dow Jones?
No, Fulcrum Therapeutics, Inc. is not included in the Dow Jones index
When was Fulcrum Therapeutics, Inc. last earnings report?
Fulcrum Therapeutics, Inc.'s most recent earnings report was on February 24, 2026
When does Fulcrum Therapeutics, Inc. report earnings?
The next expected earnings date for Fulcrum Therapeutics, Inc. is April 30, 2026
Data Sources & References
- FULC Official Website www.fulcrumtx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1680581/000119312526065197/0001193125-26-065197-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1680581/000119312526065197/0001193125-26-065197-index.htm
- FULC Profile on Yahoo Finance finance.yahoo.com/quote/FULC
- FULC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fulc